Executive Overview
Cardiovascular disease remains the leading cause of mortality in the United States, affecting roughly 10% of adults aged 30 to 79. In the constant battle against heart attacks and strokes, clinicians and patients continually seek more precise tools to forecast future risk and target preventive measures. Among the most popular diagnostic developments of the past decade is the coronary artery calcium (CAC) scan—a rapid, relatively low-cost computed tomography (CT) procedure designed to quantify calcified plaque buildup within the arteries supplying blood to the heart.
For years, the medical community has increasingly embraced CAC scans as a proactive way to peer inside the cardiovascular system. However, a major new study published on August 26 in JAMA by researchers at Northwestern Medicine challenges the notion that these scans are universally beneficial. Following more than 6,000 adults over a decade, the research team discovered that adding a CAC score to the American Heart Association’s primary cardiovascular risk calculator—known as PREVENT—yields only a minimal overall improvement for the general population.
Instead of a blanket recommendation for widespread screening, the findings indicate that coronary artery calcium scans deliver their highest value to a much narrower cohort: patients whose initial risk assessments fall squarely into borderline or intermediate categories. For low-risk individuals, routine scanning exposes patients to unnecessary radiation, additional testing, and out-of-pocket costs without translating into clear clinical benefits. For high-risk individuals, the scan is largely redundant, as current medical guidelines already recommend statin therapy regardless of calcification scores.
By defining precisely who stands to gain from CAC testing, this study provides a crucial roadmap for modern cardiology, emphasizing targeted prevention over indiscriminate screening.
Detailed Chronology: Unpacking the 10-Year Multi-Ethnic Study
To understand how researchers arrived at these practice-shifting conclusions, it is necessary to examine the architecture of the study itself. Led by senior author Dr. Nilay Shah, assistant professor of medicine in the division of cardiology at Northwestern University Feinberg School of Medicine, the investigative team set out to rigorously measure the incremental value of adding coronary artery calcium scoring to the PREVENT risk-prediction model.
The Foundation: The Multi-Ethnic Study of Atherosclerosis
The research team drew upon comprehensive data from the Multi-Ethnic Study of Atherosclerosis (MESA), a well-established, multi-center prospective cohort study designed to investigate the characteristics of subclinical cardiovascular disease and its progression.
The study cohort comprised more than 6,000 adults aged 45 to 79 who were free of clinical cardiovascular disease at baseline. At the outset of the research, every participant underwent two foundational assessments:
- The PREVENT Estimate: A calculation of their baseline likelihood of experiencing a cardiovascular event over the subsequent 10 or 30 years, derived from standard, easily accessible health metrics such as age, sex, blood pressure, and cholesterol levels.
- The Coronary Artery Calcium Score: A specialized CT scan designed to detect and quantify the presence of calcified atherosclerotic plaque within the coronary arteries.
With these dual metrics recorded at baseline, the researchers initiated a 10-year tracking period to monitor real-world health outcomes.
The Decade-Long Tracking and Real-World Outcomes
Over the subsequent decade, 6% of the study participants experienced a primary cardiovascular event, specifically a non-fatal heart attack or stroke. This longitudinal tracking allowed researchers to perform a comparative analysis, pitting risk-prediction models that incorporated calcium scores against those relying solely on the PREVENT calculator.
When evaluating the population as a whole, the addition of the calcium score offered surprisingly modest dividends. The statistical model’s discrimination—a vital metric indicating how effectively a tool distinguishes between individuals who will experience a cardiovascular event and those who will not—experienced only a minor uptick. Specifically, the C-statistic rose from 0.73 using the PREVENT tool alone to 0.75 when calcium scores were integrated.
The Turning Point: Borderline and Intermediate Risk Categories
While the macro-level improvements were minimal, a different picture emerged when researchers narrowed their focus to specific risk brackets.
The most substantial predictive gains occurred within the subset of patients whose initial PREVENT scores placed them in the borderline or intermediate risk categories—defined as individuals with a 3% to 9% estimated risk of developing heart disease over the next 10 years. For these patients, incorporating the coronary artery calcium score produced a significantly sharper image of their true physiological risk, effectively sorting them into higher- or lower-risk realities that standard equations could not resolve.
Supporting Context & Metrics: PREVENT vs. Calcium Scans
To fully grasp the clinical implications of the Northwestern Medicine study, it is helpful to examine the mechanics and underlying philosophies of the two primary risk-assessment methods evaluated by the researchers.
How the PREVENT Calculator Works
Developed under the auspices of the American Heart Association (AHA), the PREVENT calculator serves as a cornerstone of modern preventive cardiology. It is an algorithmic estimation tool designed to forecast a patient’s 10- or 30-year risk of cardiovascular disease.
PREVENT relies on routinely gathered clinical data, including:
- Age and biological sex
- Systolic and diastolic blood pressure
- Total cholesterol and high-density lipoprotein (HDL) cholesterol levels
- Diabetes status
- Smoking history
- Kidney function parameters
The great advantage of PREVENT lies in its accessibility. Because it depends entirely on standard blood panels and vital sign measurements taken during a routine doctor’s visit, it requires no specialized imaging equipment, imposes zero radiation exposure, and incurs no additional financial cost for diagnostic imaging.
How Coronary Artery Calcium Scans Work
In contrast, a coronary artery calcium scan approaches cardiovascular risk through direct visualization. Using specialized computed tomography (CT) technology, the scan takes rapid cross-sectional images of the heart to identify deposits of calcium-containing plaque within the walls of the coronary arteries.
The output of this scan is expressed as an Agatston score, commonly referred to as the calcium score:
- A score of zero: Indicates no detectable calcified plaque, strongly correlating with a very low short-term risk of a cardiovascular event.
- Scores ranging from 1 to 99: Suggest mild plaque buildup, indicating a low-to-moderate risk.
- Scores from 100 to 399: Represent moderate plaque accumulation and a substantially elevated risk of future heart disease.
- Scores of 400 and above: Indicate extensive calcification, signaling a high risk of cardiovascular events and prompting aggressive preventive interventions.
Despite their intuitive appeal—allowing patients to literally "see" their heart disease risk—CAC scans carry specific drawbacks. They require dedicated CT imaging infrastructure, involve a minor dose of ionizing radiation, and generate out-of-pocket costs that are often not covered by routine health insurance for asymptomatic screenings.
Official Statements and Expert Insights
The study’s authors emphasize that their findings are not intended to dismiss coronary artery calcium scans entirely, but rather to realign clinical practice with evidence-based precision.
Dr. Nilay Shah, the study’s senior author and an assistant professor of medicine in the division of cardiology at Northwestern University Feinberg School of Medicine, underscored the need for discernment in clinical decision-making.
"Coronary artery calcium scans are becoming more widely available and less expensive," Dr. Shah noted. "Our findings suggest that not everyone necessarily needs or would benefit from a coronary artery calcium scan for the purpose of predicting risk of heart attack and stroke."
Dr. Shah pointed directly to the potential pitfalls of overusing diagnostic imaging in low- and high-risk populations where treatment pathways are already clear:
"Routinely using a calcium scan in people who are at low risk may result in unnecessary radiation exposure, testing, and costs with unclear clinical benefits," Shah explained. "Using calcium scans in people who are at high risk is likely to result in unnecessary testing because these individuals are recommended to start a statin regardless of what the calcium scan shows."
Conversely, for those caught in the clinical gray zone, the scan proves invaluable:
"For patients at borderline risk, knowing their calcium score can help determine whether their risk is actually lower or higher than initially estimated, which can help guide treatment decisions," Shah said.
Furthermore, Dr. Shah praised the robustness of the standalone PREVENT calculator, noting that even without imaging data, the tool demonstrated impressive predictive accuracy. The research team hopes these insights will streamline how physicians utilize available resources to target preventive medications, such as cholesterol-lowering statins, to the patients who will derive the absolute maximum benefit.
Future Outlook and Unanswered Questions
While the JAMA publication provides powerful clarity regarding the utility of CAC scoring within the studied demographic, the researchers are quick to point out that important questions remain on the horizon.
Expanding Demographic Representation
The participants in the MESA cohort were aged 45 to 79 at the baseline of the study. Consequently, additional research is urgently needed to determine how effectively calcium scores enhance PREVENT risk estimates in younger adult populations. As cardiovascular disease prevention shifts toward earlier intervention—identifying subclinical atherosclerosis decades before symptoms manifest—understanding the predictive value of CAC scans in individuals under 45 will be paramount.
Furthermore, the research team emphasizes the necessity of studying how these predictive models perform across diverse racial and ethnic groups. Specifically, higher-risk demographic populations—such as South Asian and Filipino adults, who often exhibit unique cardiovascular risk profiles—require dedicated investigation to ensure risk calculators and imaging strategies are appropriately tailored.
Clinical Implications for the Future of Cardiology
As precision medicine continues to evolve, studies like this one mark a crucial maturation phase in preventive cardiology. By demonstrating that more testing does not automatically equate to better care, Northwestern Medicine’s research encourages a more thoughtful, nuanced approach to heart disease prevention.
Rather than subjecting patients to indiscriminate imaging cascades, clinicians are now better equipped to use validated risk calculators like PREVENT as the first line of defense—reserving coronary artery calcium scans as a targeted, high-value tiebreaker for the patients who need it most.
